How Tandem Diabetes Care Stock Has Fared in the Last Month
After a phenomenal run from $2.52 on January 5 to a high of $51.17 on September 13, Tandem Diabetes Care (TNDM) stock slid to $28.45 on November 20. Tandem Diabetes Care’s revenue rose an impressive 71.33% from $27.0 million in the third quarter of 2017 to $46.26 million in the third quarter of 2018. Tandem Diabetes incurred a net loss of $73.03 million in 2017.